ISRCTN40811115已完成未知
The therapeutic role of chronic omega-3 fatty acid supplementation in type 1 diabetes patients
eeds Beckett University0 个研究点目标入组 20 人开始时间: 2017年6月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32787879/ results (added 17/08/2020) 2022 Results article in https://doi.org/10.1177/14791641221103217 (added 19/07/2024)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Current inclusion criteria as of 01/04/2020:
- •1. Male or female and aged 18-65 years old
- •2. Free from any diabetes-related complications (except background diabetic retinopathy)
- •3. Not known to be allergic or sensitive to fish, fish oil, or n3-FA products
- •4. Not known to have or have had documented atrial fibrillation
- •5. Not known to have documented liver problems or abnormal liver function
- •6. Will not be pregnant, planning to become pregnant within 12 months, or currently breastfeeding
- •7. Not known to have documented hematological abnormalities or experience heavy menstrual bleeding
- •8. Not taking prescribed medication knowing to interfere with study procedures
- •9. Treated with a stable insulin regimen composed of either:
- •9.1. A combination of slow/long-acting insulin glargine/detemir and a fast-acting insulin analogue lispro/aspart/glulisine
- •9.2. Continuous subcutaneous insulin infusion therapy (insulin pump therapy)
- •10. Have an HbA1c of <11% (97 mmol/mol)
- •11. Using the carbohydrate counting method for administering meal-time insulin
- •Previous inclusion criteria:
- •1. Male or female and aged 18-65 years old
- •2. Free from any diabetes-related complications (except background diabetic retinopathy)
- •3. Not known to be allergic or sensitive to fish, fish oil, or n3-FA products
- •4. Not known to have or have had documented atrial fibrillation
- •5. Not known to have documented liver problems or abnormal liver function
- •6. Will not be pregnant, planning to become pregnant within 12 months, or currently breastfeeding
- •7. Not known to have documented hematological abnormalities or experience heavy menstrual bleeding
- •8. Not taking any prescribed medication other than insulin
- •9. Treated with a stable insulin regimen composed of either:
- •9.1. A combination of slow/long-acting insulin glargine/detemir and a fast-acting insulin analogue lispro/aspart/glulisine
- •9.2. Continuous subcutaneous insulin infusion therapy (insulin pump therapy)
- •10. Have an HbA1c of <11% (97 mmol/mol)
- •11. Using the carbohydrate counting method for administering meal-time insulin
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Incorporation of omega-3 fatty acidsISRCTN18364209BASF AS20
已完成
不适用
Evaluation of the effect of supplementation with omega-3 fatty acids and vitamin D on blood sugar, lipids, cholesterol and inflammation markers, and body weight, in patients with diabetes mellitusType 2 Diabetes MellitusISRCTN97792326niversidad Autonoma del Estado de Mexico120
已完成
不适用
Omega-3 Fatty Acids and/or Multi-domain Intervention in the Prevention of Age-related Cognitive DeclineFrail Elderly SubjectsNCT00672685University Hospital, Toulouse1,680
已完成
2 期
Evaluating therapeutic effects of omega-3 fatty acids on anemia and nutritional status in hemodialysis patients with depressioCondition 1: Anemia. Condition 2: Nutritional Status. Condition 3: Depression. Condition 4: Hemodialysis.Anaemia in other chronic diseases classified elsewhereProtein-energy malnutrition of moderate and mild degreeDepressive episodeExtracorporeal dialysisD63.8*IRCT201202203043N5Tehran University of Medical Sciences50
尚未招募
3 期
Influence of omega-3 fatty acids on health care provider burn outIRCT20090304001743N14Hamedan University of Medical Sciences60